Cholest-5-en-3β-ylmyristat
|
|
|
- CAS-Nr.
- 1989-52-2
- Bezeichnung:
- Cholest-5-en-3β-ylmyristat
- Englisch Name:
- Cholesteryl myristate
- Synonyma:
- CM;C14:0 CE;tetradecanoate;cholanolacidester;Cholestryl myristate;CHOLESTERYL MYRISTATE;CHOLESTEROL MYRISTATE;Cholestryl myristic acid;Cholesterol Myristate >Cholesterol=tetradecanoate
- CBNumber:
- CB4280873
- Summenformel:
- C41H72O2
- Molgewicht:
- 597.01
- MOL-Datei:
- 1989-52-2.mol
|
Cholest-5-en-3β-ylmyristat Eigenschaften
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher |
Xi |
|
|
| R-S?tze: |
36/37/38 |
|
|
| S-S?tze: |
26-36 |
|
|
| WGK Germany |
3 |
|
|
| TSCA |
TSCA listed |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
| P301+P312 |
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
| P330 |
Mund ausspülen. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Cholest-5-en-3β-ylmyristat Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Beschreibung
Cholesteryl myristate is a cholesterol ester. Levels of cholesteryl myristate are increased in the serum, liver, and aorta in rabbits fed a high-cholesterol diet and positively correlate with development of non-alcoholic fatty liver disease (NAFLD). Plasma levels of cholesteryl myristate also positively correlate with the presence of unstable atherosclerotic plaques in coronary artery disease. Cholesterol myristate has been used in the composition of lipid nanoparticles as drug carrier systems for drugs with low water solubility.
Verwenden
Cholesteryl Myristate is a natural steroid present in traditional Chinese medicine or used in tribal medicine.
Definition
ChEBI: A cholesterol ester obtained by the formal condensation of the hydroxy group of cholesterol with the carboxy group of myristic acid.
l?uterung methode
Crystallise the myristate ester from Me2CO, EtOH/EtOAc or EtOH/Et2O or n-pentanol. Purify it also by column chromatography on silica gel and eluting with MeOH then evaporating to dryness. Recrystallise it and finally, dry it in vacuo over P2O5 and store it at -20o. [Labarière et al. Analyt Chem 30 1466 1958, Malanik & Malat Anal Chim Acta 76 464 1975, Beilstein 6 III 2638].
Cholest-5-en-3β-ylmyristat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Cholest-5-en-3β-ylmyristat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 133)Lieferanten
1989-52-2(Cholest-5-en-3β-ylmyristat)Verwandte Suche:
- 3β-Hydroxy-5-cholestene 3-tetradecanoate, 5-Cholesten-3β-ol 3-tetradecanoate, Cholesteryl tetradecanoate
- Cholest-5-en-3β-ol tetradecanoate
- Cholesterol=tetradecanoate
- Myristic acid 3β-cholesteryl ester
- Tetradecanoic acid 3β-cholesteryl ester
- Cholesteryl myristate,97%,liquid crystal
- MYRISTIC ACID CHOLESTEROL ESTER
- (3β)-cholest-5-en-3-yltetradecanoate
- 3β-tetradecanoyloxycholest-5-ene
- Cholest-5-en-3-ol (3beta)-, tetradecanoate
- Cholest-5-en-3-yl myristate
- Cholestryl myristate
- tetradecanoate
- CHOLESTERYL MYRISTATE (TETRADECANOATE)
- CHOLESTERYL MYRISTATE, LIQUID CRYSTAL 99%
- CHOLESTERYL TETRADECANOATE
- CHOLESTERYL TETRADODEDECANOATE
- CHOLESTERYL MYRISTATE
- Cholest-5-en-3beta-yl myristate
- CHOLESTEROL MYRISTATE
- 3BETA-HYDROXY-5-CHOLESTENE 3-TETRADECANOATE
- [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] tetradecanoate
- 5-CHOLESTEN-3-BETA-OL MYRISTATE
- 5-CHOLESTEN-3BETA-OL 3-TETRADECANOATE
- 5-Cholesten-3β-ol 3-tetradecanoate
- 3β-hydroxy-5-cholestene 3-tetradecanoate
- Cholestryl myristic acid
- Cholesteryl Tetradecanoate (Myristate)
- Cholesteryl myristate, liquid crystal, 97%
- Cholesterol Myristate >
- Cholest-5-en-3-ol (3β)-, 3-tetradecanoate
- C14:0 CE
- (3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl tetradecanoate
- Cholesterol myristate, >98%
- Potassium Channel,inhibit,Endogenous Metabolite,Inhibitor,Nicotinic acetylcholine receptors,nAChR,Gamma-aminobutyric acid Receptor,γ-Aminobutyric acid Receptor,Cholesterol myristate,GABA Receptor,KcsA
- 5-CHOLESTEN-3β-OL MYRISTATE
- 5-Cholesten-3β-Ol 3-Tridecanoate
- cholanolacidester
- CM
- 1989-52-2
- C41H74O2
- C41H72O2
- BioChemical
- Biochemicals and Reagents
- Cholesterol and Derivatives
- Lipids
- Sterols
- Steroids
- Cholesteryl Compounds (Liquid Crystals)
- Functional Materials
- Liquid Crystals & Related Compounds
